Medicare Enrolled

Dr. Dania Masseoud, M.D.

Rheumatology · Atlanta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3193 HOWELL MILL RD NW, Atlanta, GA 30327
4046039090
In practice since 2006 (19 years)
NPI: 1568471258 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Masseoud from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Masseoud? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Masseoud

Dr. Dania Masseoud is a rheumatology specialist in Atlanta, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Masseoud performed 14,259 Medicare services across 327 unique beneficiaries.

Between the years covered by Open Payments, Dr. Masseoud received a total of $15,840 from 69 pharmaceutical and/or device companies across 895 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Masseoud is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 27% volume in GA $15,840 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,259
Medicare services
Top 27% in GA for rheumatology
327
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~750 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
12,350 $10 $71
Denosumab injection (Prolia/Xgeva) 1,320 $18 $81
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
301 $59 $152
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
171 $97 $614
New patient office visit, complex (60-74 min) 64 $153 $500
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
32 $53 $309
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
21 $10 $99
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
87.8% high complexity
9.6% medium
2.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$15,840
Total received (2018-2024)
Avg $2,263/year across 7 years
Top 22% in GA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
895
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,772 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$68 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,677
2023
$2,911
2022
$2,475
2021
$1,928
2020
$1,513
2019
$2,265
2018
$2,070

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$468
ABBVIE INC.
$285
AstraZeneca Pharmaceuticals LP
$212
Janssen Biotech, Inc.
$200
PFIZER INC.
$195
Novartis Pharmaceuticals Corporation
$174
GlaxoSmithKline, LLC.
$154
UCB, Inc.
$143
Mallinckrodt Hospital Products Inc.
$134
Collegium Pharmaceutical, Inc.
$110
ANI Pharmaceuticals, Inc.
$83
E.R. Squibb & Sons, L.L.C.
$82
Lundbeck LLC
$74
SOBI, INC
$68
GENZYME CORPORATION
$48
Fresenius Kabi USA, LLC
$40
Organon Llc
$39
IDORSIA PHARMACEUTICALS US INC
$35
Lilly USA, LLC
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Alexion Pharmaceuticals, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$21
Curonix LLC
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
Top 3 companies account for 36.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,389
ABBVIE INC.
$1,342
Janssen Biotech, Inc.
$1,308
Novartis Pharmaceuticals Corporation
$1,274
PFIZER INC.
$1,165
UCB, Inc.
$1,010
Horizon Therapeutics plc
$668
AstraZeneca Pharmaceuticals LP
$633
AbbVie Inc.
$564
Mallinckrodt Hospital Products Inc.
$559
AbbVie, Inc.
$433
GlaxoSmithKline, LLC.
$382
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$267
Lilly USA, LLC
$260
Collegium Pharmaceutical, Inc.
$247
SANOFI-AVENTIS U.S. LLC
$236
Biohaven Pharmaceuticals, Inc.
$228
GENZYME CORPORATION
$171
Lundbeck LLC
$163
E.R. Squibb & Sons, L.L.C.
$159
Boehringer Ingelheim Pharmaceuticals, Inc.
$141
Sobi, Inc
$141
Horizon Pharma plc
$140
Celgene Corporation
$138
Genentech USA, Inc.
$116
SOBI, INC
$115
ANI Pharmaceuticals, Inc.
$106
Mallinckrodt Enterprises LLC
$96
Biohaven Pharmaceutical Holding Company Ltd.
$93
Sandoz Inc.
$81
TerSera Therapeutics LLC
$78
Eisai Inc.
$76
Teva Pharmaceuticals USA, Inc.
$70
BioDelivery Sciences International, Inc.
$67
IDORSIA PHARMACEUTICALS US INC
$56
Boston Scientific Corporation
$56
Flexion Therapeutics, Inc.
$49
FIDIA PHARMA USA INC.
$47
Mallinckrodt LLC
$44
Bioventus LLC
$41
Fresenius Kabi USA, LLC
$40
DePuy Synthes Sales Inc.
$40
Organon Llc
$39
MEDEXUS PHARMA, INC.
$38
Merck Sharp & Dohme Corporation
$34
Assertio Therapeutics, Inc.
$30
Shionogi Inc
$28
Aurinia Pharma U.S., Inc.
$25
RedHill Biopharma Inc.
$25
Bausch Health US, LLC
$23
Purdue Pharma L.P.
$23
EISAI INC.
$22
Alexion Pharmaceuticals, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$21
IMPEL PHARMACEUTICALS INC.
$20
Mylan Institutional Inc.
$18
Octapharma USA, Inc.
$18
Scilex Pharmaceuticals Inc.
$18
Azurity Pharmaceuticals, Inc.
$17
Curonix LLC
$16
Organon LLC
$14
Kaleo, Inc.
$14
MEDAC PHARMA, INC.
$14
Shire North American Group Inc
$13
Zyla Life Sciences
$13
Daiichi Sankyo Inc.
$12
Mission Pharmacal Company
$12
Egalet US Inc
$12
Pernix Therapeutics Holdings, Inc.
$12
Top 3 companies account for 31.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMJEVITA · Actemra · Aimovig · Aquoral · BELBUCA · BELSOMRA · BENLYSTA · BUNAVAIL 2.1 mg 30-count box · Bimzelx · COSENTYX · Cambia · Cimzia · DUEXIS · Dayvigo · Durolane · EVENITY · EVZIO · Enbrel · FORTEO · GENERAL PAIN MANAGEMENT · HUMIRA · HYALGAN · HYRIMOZ · Horizant · Humira · Hymovis · IDACIO · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MIGRANAL · MOVANTIK · Morphabond ER · Movantik · NUCALA · NURTEC ODT · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · ORTHOVISC · OXAYDO · Otezla · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PURIFIED CORTROPHIN GEL · Prolia · QULIPTA · QUVIVIQ · RAYOS · RELISTOR · RELISTOR ORAL · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · SPRIX · STELARA · STRENSIQ · SYMPROIC · Symproic · TALTZ · TAVNEOS · TREMFYA · TRINTELLIX · Trudhesa · Tyenne · VYEPTI · XELJANZ · XTAMPZA · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Atlanta?
Compare rheumatologists in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
87
Per 100K population
8.1
County median income
$91,490
Nearest hospital
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
2.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Masseoud is a mixed practice specialist, with above-average Medicare volume (top 27% in GA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Masseoud experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Masseoud performed 12,350 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Masseoud receive payments from pharmaceutical companies?
Yes. Dr. Masseoud received a total of $15,840 from 69 companies across 895 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Masseoud's costs compare to other rheumatologists in Atlanta?
Dr. Masseoud's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Masseoud) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →